These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36400537)

  • 1. The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease.
    Ramos K; Guilliams KP; Fields ME
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1167-1186. PubMed ID: 36400537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle Cell Disease and Stroke.
    Hirtz D; Kirkham FJ
    Pediatr Neurol; 2019 Jun; 95():34-41. PubMed ID: 30948147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.
    Hulbert ML; McKinstry RC; Lacey JL; Moran CJ; Panepinto JA; Thompson AA; Sarnaik SA; Woods GM; Casella JF; Inusa B; Howard J; Kirkham FJ; Anie KA; Mullin JE; Ichord R; Noetzel M; Yan Y; Rodeghier M; Debaun MR
    Blood; 2011 Jan; 117(3):772-9. PubMed ID: 20940417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in neuroimaging to improve care in sickle cell disease.
    Jordan LC; DeBaun MR; Donahue MJ
    Lancet Neurol; 2021 May; 20(5):398-408. PubMed ID: 33894194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging in assessment of risk of stroke in children with sickle cell disease.
    Arkuszewski M; Melhem ER; Krejza J
    Adv Med Sci; 2010; 55(2):115-29. PubMed ID: 21109500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
    Mack AK; Thompson AA
    J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor and neuroimaging in pediatric patients with sickle cell disease.
    Mahmoud AA; Abd El Naby SA; Abdelgawad AS; Rizq MS; Abd El Hady NMS
    Pediatr Res; 2023 Jun; 93(7):1922-1926. PubMed ID: 36774398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke in sickle cell disease and the promise of recent disease modifying agents.
    Runge A; Brazel D; Pakbaz Z
    J Neurol Sci; 2022 Nov; 442():120412. PubMed ID: 36150233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease.
    Coloigner J; Phlypo R; Coates TD; Lepore N; Wood JC
    Brain Connect; 2017 Sep; 7(7):443-453. PubMed ID: 28747064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease.
    Strouse J
    Handb Clin Neurol; 2016; 138():311-24. PubMed ID: 27637966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease.
    DeBaun MR; Schatz J; Siegel MJ; Koby M; Craft S; Resar L; Chu JY; Launius G; Dadash-Zadeh M; Lee RB; Noetzel M
    Neurology; 1998 Jun; 50(6):1678-82. PubMed ID: 9633710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and environmental contributors to neurological complications in sickle cell disease.
    Karkoska KA; Gollamudi J; Hyacinth HI
    Exp Biol Med (Maywood); 2023 Aug; 248(15):1319-1332. PubMed ID: 37688519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography.
    Powars DR; Conti PS; Wong WY; Groncy P; Hyman C; Smith E; Ewing N; Keenan RN; Zee CS; Harold Y; Hiti AL; Teng EL; Chan LS
    Blood; 1999 Jan; 93(1):71-9. PubMed ID: 9864148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.
    Choi S; Bush AM; Borzage MT; Joshi AA; Mack WJ; Coates TD; Leahy RM; Wood JC
    Neuroimage Clin; 2017; 15():239-246. PubMed ID: 28540180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging.
    Gold JI; Johnson CB; Treadwell MJ; Hans N; Vichinsky E
    Pediatr Hematol Oncol; 2008 Jun; 25(5):409-21. PubMed ID: 18569843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.
    Buchanan ID; James-Herry A; Osunkwo I
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Connectivity Decreases with Metabolic Stress in Sickle Cell Disease.
    Fields ME; Mirro AE; Guilliams KP; Binkley MM; Gil Diaz L; Tan J; Fellah S; Eldeniz C; Chen Y; Ford AL; Shimony JS; King AA; An H; Smyser CD; Lee JM
    Ann Neurol; 2020 Nov; 88(5):995-1008. PubMed ID: 32869335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.